Clinical trials: Radiation Pneumonitis
Covid19
Low Dose Radiotherapy for COVID-19 Pneumonitis
SARS-CoV-2 is causing an unprecedented stress on healthcare systems around the world, due to its high rate of infection and the high morbidity and mortality.
- Trial name
- LOWRAD-Cov19 (NCT04420390)
- Testing
- Radiotherapy
- Where
- Spain
- Volunteers
- 41 people
- Sponsor
- Hospital San Carlos, Madrid
Pneumonitis
Single-cell Sequencing of BLF to Guide the Treatment of Radiation Pneumonitis or Immune Checkpoint Inhibitor Pneumonitis
A multicenter, exploratory clinical research, to map the radiation or immune checkpoint inhibitor pneumonitis in patients with alveolar lavage single-celled map.
- Trial name
- NCT05455034
- Testing
- single-cell sequencing
- Where
- China
- Volunteers
- 40 people
- Sponsor
- Xinqiao Hospital of Chongqing
Lung Cancer, Lung Function Decreased
Use of Dual Energy Computed Tomography in Thoracic Radiotherapy Planning.
This is a prospective observational study aiming: 1) To quantify lung function using perfusion dual energy computed tomography (DECT) and use this information at the time of treatment planning with preferential sparing of…
- Conditions
- Lung Cancer, Lung Function Decreased, Radiation Pneumonitis
- Trial name
- NCT04863027
- Testing
- Thoracic radiotherapy
- Where
- Canada
- Volunteers
- 60 people
- Sponsor
- Centre hospitalier de l'Université de Montréal (CHUM)
Lung Neoplasms, Radiation Pneumonitis
Application of 4DCT-Based Pulmonary Ventilation Imaging in Lung Cancer Radiotherapy
This retrospective single-center study investigates whether four-dimensional CT (4DCT)-based lung ventilation imaging can guide functional lung avoidance radiotherapy (FLAR) for patients with primary lung cancer.
- Trial name
- FLAR-4DCT (NCT07312682)
- Where
- China
- Volunteers
- 202 people
- Sponsor
- The Second Affiliated Hospital of Chongqing Medical University
Radiation; Adverse Effect, Pneumonitis
Predictors of Radiation Pneumonitis in Locally Advanced Lung Cancer Treated With Chemoradiation
Lung cancer [LC] is the leading cause of cancer death worldwide. The standard treatment of locally advanced lung cancer unresectable or marginally resectable is combination therapy with radical or preoperative chemoradiation.
- Trial name
- NCT01580579
- Where
- Mexico
- Volunteers
- 62 people
- Sponsor
- Instituto Nacional de Cancerologia de Mexico
COVID-19
COVID-19 Pneumonitis Low Dose Lung Radiotherapy (COLOR-19)
Low-dose radiotherapy treatment delivered to both lungs in patients with immune-related pneumonia following COVID-19 infection is backed up by biological and clinical bases that justify its use as a possible therapeutic option in…
- Trial name
- COLOR-19 (NCT04377477)
- Testing
- Single fraction whole lung radiotherapy
- Where
- Italy
- Volunteers
- 3 people
- Sponsor
- Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Radiation Pneumonitis, Lung Cancer
Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of HL301 on Radiation Pneumonitis in Non-small Cell Lung Cancer Patients
The purpose of this clinical trial is to evaluate the safety when HL301 is administered to unresectable non-small cell lung cancer patients who receive chemoradiotherapy with Paclitaxel and Carboplatin and to search for a…
- Trial name
- NCT04632342
- Testing
- HL301 tablet 300mg
- Where
- South Korea
- Volunteers
- 87 people
- Sponsor
- Hanlim Pharm. Co., Ltd.
Non Small Cell Lung Cancer, Stage III NSCLC
A Phase 2 Trial of Almonertinib With Concurrent Radiotherapy in The Treatment of Local Advanced EGFR-mutant NSCLC
Previous clinical studies showed there is a potential value of EGFR-TKI in local advanced EGFR-mutant NSCLC, while the risk of radiation pneumonia in combination of EGFR-TKI with thoracic radiotherapy is unknown.
- Conditions
- Non Small Cell Lung Cancer, Stage III NSCLC, EGFR Activating Mutation
- Trial name
- NCT04636593
- Testing
- Almonertinib
- Where
- China
- Volunteers
- 43 people
- Sponsor
- First People's Hospital of Hangzhou
Lung Cancer (NSCLC), Lung Cancer (SCLC)
Multi-Omics Prediction of Radiation Lung Injury in Immunotherapy-Treated Lung Cancer Patients
This prospective study aims to develop a multi-omics-based predictive model for radiation pneumonitis in lung cancer patients receiving sequential immunotherapy and thoracic radiotherapy.
- Trial name
- NCT07742800
- Testing
- No Intervention: Observational Cohort
- Where
- China
- Volunteers
- 160 people
- Sponsor
- HAN GUANG
COVID-19 Pneumonitis
Low Dose Whole Lung Radiotherapy for Older Patients With COVID-19 Pneumonitis
Low dose whole lung radiotherapy may improve survival of older patients with COVID-19 pneumonitis
- Trial name
- NCT04493294
- Testing
- Low dose whole lung radiotherapy for older patients with COVID-19 pneumonitis
- Volunteers
- 500 people
- Sponsor
- International Geriatric Radiotherapy Group
Breast Cancer, Radiation Pneumonia
Correlation Between COVID-19 and Radiation Pneumonitis in Breast Cancer
This study was designed as a single-center retrospective analysis aimed at investigating whether COVID-19 infection increases the risk or burden of radiation-induced pneumonitis in breast cancer patients.
- Conditions
- Breast Cancer, Radiation Pneumonia, COVID-19
- Trial name
- NCT07188116
- Testing
- COVID-19
- Where
- China
- Volunteers
- 200 people
- Sponsor
- Zhejiang Hospital
Lung Cancer, Radiation-Induced Disorder
Functional Lung Avoidance SPECT-guided Radiation Therapy of Lung Cancer
Study aims to determine if functional lung avoidance based on perfusion single photon emission (SPECT)/CT scan, improves toxicity outcomes for patients with advanced lung cancer undergoing chemo-radiotherapy.
- Conditions
- Lung Cancer, Radiation-Induced Disorder, Radiation Pneumonitis, Pulmonary Disease
- Trial name
- ASPECT (NCT04676828)
- Testing
- Single-photon-emission CT scan
- Where
- 2 sites in Australia, Denmark
- Volunteers
- 90 people
- Sponsor
- University of Aarhus
Lung Cancer, Radiation Pneumonitis
Mitigation of Radiation Pneumonitis and Fibrosis
This project will test the effect of enalapril to mitigate the lung damage that can occur as a side effect of radiation therapy for lung cancer or other intrathoracic cancers.
- Trial name
- NCT01754909
- Testing
- Enalapril
- Where
- 3 sites in United States
- Volunteers
- 50 people
- Sponsor
- VA Office of Research and Development
Carcinoma, Non-Small-Cell Lung
IMFINZI Specific-Clinical Experience Investigation in Patients With NSCLC After Definitive Chemoradiation Therapy
To investigate the impact of presence/absence or grade of radiation pneumonitis before starting IMFINZI, on the onset of interstitial lung disease (including radiation pneumonitis) after starting IMFINZI, in the real world in…
- Trial name
- NCT03643484
- Where
- 37 sites in Japan
- Volunteers
- 634 people
- Sponsor
- AstraZeneca
Radiation Pneumonitis
Hyperbaric Oxygen in the Prevention of Radiation Pneumonitis
Radiotherapy is one of the important treatments to improve the survival rate of breast cancer patients, but also has the risk of radiation lung injury, which can develop into pulmonary fibrosis.
- Trial name
- NCT05189496
- Testing
- hyperbaric oxygen therapy
- Where
- China
- Volunteers
- 380 people
- Sponsor
- Guangdong Provincial People's Hospital